Current HIV-1 preventative or suppressive treatments consist of direct-acting antivirals that intervene in HIV-1 replication and are suitable in suppressing productive HIV-1 infection of CD4+ target cells [33]. The gene discussed is CD4; the disease is HIV-1 infection.